Ornithine Alpha-Ketoglutarate (OKG).

Ornithine is the direct product of arginase acting on arginine, so the two are a precursor and product pair on the same enzyme. Loading either shifts the balance of the urea cycle.

Arginine is hydrolysed to ornithine and urea in one step, and ornithine is recycled back toward arginine through citrulline. That loop is why the two are formulated together.

Ornithine accepts a carbamoyl group to become citrulline, which is then rebuilt into arginine, so the three sit in strict sequence. Supplying ornithine adds substrate at the entry point of that sequence.

Citrulline is made from ornithine and returns to ornithine each turn of the cycle, so the two are consecutive intermediates. That sequence is settled biochemistry.

Alpha-ketoglutarate is aminated to glutamate and then to glutamine, so the AKG half of this molecule feeds the glutamine pool directly. Ornithine with AKG is used in formulation to support that nitrogen route.

Ornithine decarboxylase converts ornithine to putrescine, which is extended to spermidine and spermine, making ornithine the committed entry point for polyamine synthesis. Both compounds sit on the same pathway.

Arginase, the enzyme that generates ornithine from arginine, holds two manganese ions in its active site. Manganese status therefore sets the capacity of the step that produces ornithine endogenously.

Ornithine aminotransferase, which routes ornithine toward glutamate and proline, is a pyridoxal 5-phosphate enzyme. B6 status decides how much ornithine leaves the urea cycle into that branch.

Carbamoyl phosphate synthesis and argininosuccinate formation both consume ATP, which is active only as a magnesium complex. Magnesium status therefore underpins the throughput of the cycle ornithine enters.

Branched-chain aminotransferase moves the amino group of leucine onto alpha-ketoglutarate to form glutamate, so AKG is the obligatory acceptor for leucine catabolism. Supplying AKG alongside branched-chain amino acids widens that acceptor pool.

Valine hands its amino group to alpha-ketoglutarate through the same aminotransferase, generating glutamate and the corresponding keto acid. AKG is the shared acceptor for all three branched-chain amino acids.

OKG dissociates in solution, so an OKG dose delivers free ornithine plus alpha-ketoglutarate on a fixed stoichiometry. Anyone comparing an OKG dose with an ornithine hydrochloride dose is comparing different amounts of the same base. Rodent work has argued the salt behaves differently from its separated components, which is a claim about the pair, not about ornithine alone.

Ornithine aminotransferase converts ornithine into the direct precursor of proline. Proline is the amino acid the body needs in bulk for collagen, and it is also the one hydroxylated during collagen maturation. The pairing is a straight precursor relationship rather than a measured combination effect.

Collagen prolyl-4-hydroxylase consumes one molecule of 2-oxoglutarate for every proline it hydroxylates, splitting it to succinate and CO2. Ascorbate keeps the iron in the active site reduced so the enzyme can keep turning over. Alpha-ketoglutarate and vitamin C therefore sit on opposite sides of the same catalytic cycle.

Every enzyme that uses alpha-ketoglutarate as a co-substrate holds a ferrous iron at its active site, including the collagen hydroxylases and the carnitine synthesis enzyme. Without iron in that site the reaction does not proceed regardless of how much alpha-ketoglutarate is present. This is a cofactor requirement, not a reason to add iron to a formula.

The last step that makes carnitine from gamma-butyrobetaine consumes alpha-ketoglutarate alongside iron and ascorbate. Supplemental carnitine bypasses that step entirely, so the two ingredients meet the same endpoint from different directions. Read it as pathway overlap rather than an additive effect.

Collagen peptides supply the glycine, proline and hydroxyproline building blocks; OKG supplies the ornithine that converts to proline and the alpha-ketoglutarate the hydroxylation step consumes. The two therefore cover substrate and co-substrate. No combination trial has measured the pair together in people.

System y+ carriers move all three basic amino acids, so a large dose of one reduces uptake of the others at the intestinal and renal membrane. Taking gram doses of lysine and OKG in the same sitting sets up that competition. Spacing the doses is the practical response.

Arginine:glycine amidinotransferase transfers the guanidino group from arginine to glycine, releasing ornithine as the other product. That reaction is the committed step of endogenous creatine synthesis. Ornithine feeds back on the enzyme, so an ornithine load and glycine availability pull on the same node from opposite ends.

Guanidinoacetate synthesis produces ornithine, and ornithine exerts product inhibition on the transferase that makes it. Supplemental creatine reduces demand on that endogenous route by a separate feedback mechanism. The interaction is metabolic bookkeeping and has not been quantified as a combined supplement effect in people.

Alpha-ketoglutarate leaves the TCA cycle only through the dehydrogenase complex, and that complex cannot decarboxylate it without thiamine pyrophosphate. Low thiamine status is a classic bottleneck at exactly this step, which is why alpha-ketoglutarate accumulates when it is deficient. The pairing supports normal energy metabolism at the step the ingredient enters.

The E3 subunit shared by the alpha-ketoglutarate, pyruvate and branched-chain dehydrogenase complexes is a flavoprotein. It re-oxidises the lipoamide arm so the complex can run another cycle. Riboflavin supplies that flavin.

Oxidising alpha-ketoglutarate to succinyl-CoA reduces NAD+ to NADH. The NAD+ pool derives from niacin and its relatives. Without the acceptor the reaction stalls no matter how much substrate is supplied.

The product of the alpha-ketoglutarate dehydrogenase step is succinyl-CoA, so a coenzyme A molecule is consumed at that reaction. Pantothenic acid is the vitamin from which CoA is built. This is the fourth cofactor on a single reaction that alpha-ketoglutarate feeds.

The swinging lipoamide arm carries the succinyl group between the subunits of the complex. Supplemental lipoic acid is not the source of that protein-bound cofactor, which is synthesised in the mitochondrion, so the connection is mechanistic rather than a supply relationship. It is worth naming precisely because the two are so often paired on that basis.

Ornithine and alpha-ketoglutarate both sit on the routes that dispose of amino nitrogen, through the urea cycle and through glutamate and glutamine synthesis. A high protein load raises the nitrogen flux through those routes. The clinical work on OKG was done in hospital nutrition settings rather than alongside sports protein, so extending it to that context is inference.

HMB acts on protein breakdown signalling, while OKG supplies substrate for glutamine, proline and polyamine synthesis. The rationale for combining them is that they sit on different arms of the same balance sheet. No trial has measured them together, so this is formulation rationale rather than evidence.

Rodent studies have described changes in ileal mucosal microbiota and metabolite profiles with ornithine alpha-ketoglutarate feeding. That is a microbial community measurement in animals, not a demonstrated effect in people, and it says nothing about a specific probiotic strain. Read it as a reason the pairing has been proposed, not as support for it.

Colonocytes take butyrate as a preferred fuel, and glutamine derived from ornithine and alpha-ketoglutarate metabolism is the corresponding fuel for the small intestinal epithelium. The two therefore feed different segments of the same tissue. This is mechanistic reasoning about substrate supply, not a tested combination.